Lynx1 Capital Management LP
CIK 1910456 · Holdings on Jun 30, 2024 · First reported Aug 14, 2024
Top ten holdings
Q2 2024- MRUS25.76%
- STOK25.27%
- GHRS16.69%
- CCCC11.47%
- TCRX11.03%
- CGEM2.37%
- ALLO1.87%
- LBPH1.63%
- 7027121001.45%
- CABA1.33%
Share classes counted separately98.87%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- STOKWeight increased · +12.42 pp12.85% → 25.27%Shares +1.49M (+40.26%)
- MRUSWeight increased · +8.26 pp17.50% → 25.76%Shares -302.30K (-20.03%)
- CABAWeight decreased · -7.82 pp9.15% → 1.33%Shares -1.59M (-76.37%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 17
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | MRUSMERUS NV View history and evidence | $71.40M | 25.76% | 1.21M shares | 17.50% → 25.76%+8.26 pp -302.30K (-20.03%) | Reduced | ↗▾ |
| 02 | STOKSTOKE THERAPEUTICS INC View history and evidence | $70.05M | 25.27% | 5.19M shares | 12.85% → 25.27%+12.42 pp +1.49M (+40.26%) | Added | ↗▾ |
| 03 | GHRSGH RESEARCH PLCORDINARY SHARES View history and evidence | $46.25M | 16.69% | 3.97M shares | 9.09% → 16.69%+7.60 pp +656.16K (+19.82%) | Added | ↗▾ |
| 04 | CCCCC4 THERAPEUTICS INCCOM STK View history and evidence | $31.79M | 11.47% | 6.88M shares | 7.65% → 11.47%+3.82 pp +3.25M (+89.30%) | Added | ↗▾ |
| 05 | TCRXTSCAN THERAPEUTICS INC View history and evidence | $30.56M | 11.03% | 5.22M shares | 10.68% → 11.03%+0.35 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | CGEMCULLINAN THERAPEUTICS INC View history and evidence | $6.58M | 2.37% | 377.32K shares | Prior unavailable +377.32K | New | ↗▾ |
| 07 | ALLOALLOGENE THERAPEUTICS INC View history and evidence | $5.19M | 1.87% | 2.23M shares | Prior unavailable +2.23M | New | ↗▾ |
| 08 | LBPHLONGBOARD PHARMACEUTICALS IN View history and evidence | $4.52M | 1.63% | 167.32K shares | Prior unavailable +167.32K | New | ↗▾ |
| 09 | 702712100PASSAGE BIO INC View history and evidence | $4.02M | 1.45% | 5.06M shares | 1.68% → 1.45%-0.23 pp +211.76K (+4.37%) | Added | ↗▾ |
| 10 | CABACABALETTA BIO INC View history and evidence | $3.68M | 1.33% | 492.10K shares | 9.15% → 1.33%-7.82 pp -1.59M (-76.37%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 6
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| NVLS ALPINE IMMUNE SCIENCES INC | Non-derivative | -2,253,183 | -$89.32M | SEC filing ↗ | SEC filing ↗ |
| SLN SILENCE THERAPEUTICS PLC-ADR | Non-derivative | -526,642 | -$11.38M | SEC filing ↗ | SEC filing ↗ |
| AUTL AUTOLUS THERAPEUTICS PLC | Non-derivative | -1,390,160 | -$8.87M | SEC filing ↗ | SEC filing ↗ |
3 / 6 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1910456 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-14
Amendments and versions
{
"amendments_merged": [
{
"action": "MERGE_ADD",
"accession": "0001892688-24-000100",
"cover_total": 1266000,
"filing_date": "2024-08-19",
"claimed_type": "NEW HOLDINGS",
"confidential": false,
"positions_added": 0,
"positions_restated": 1,
"positions_cancelled": 0
}
],
"prior_versions": null,
"cover_table_value": 275939282
}Take these holdings further.
This page includes 17 of 17 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 17 of 17 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1910456","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1910456","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.